medigraphic.com

2017, Number 6

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2017; 55 (6)

Outcome of acute kidney injury in critically ill patients treated with intermittent hemodialysis versus CRRT

Ávalos-López M, Pérez-López MJ, Aguilar-Martínez C, Díaz-Franco AMC, Esquivel-Chávez A, Baltazar-Torres JA

Language: Spanish
References: 26
Page: 696-703
PDF size: 305.85 Kb.


ABSTRACT

Background: Acute kidney injury (AKI) is common in critically ill patients and it is associated with poor outcome. Some patients require renal replacement therapy (RRT), and the most frequently used are intermittent hemodialysis (IHD) and continuous renal replacement therapies (CRRT). Current evidence is insufficient to conclude which modality is most appropriate to treat critically ill patients with AKI.
Methods: We reviewed the clinical records of critically ill patients with stage 3 AKI treated with RRT. We recorded demographic and clinical data and serum creatinine. We compared the evolution and prognosis of patients treated with IHD versus those treated with CRRT by Student’s t test, chi squared, Kaplan-Meier curves, and Cox regression. Logistic regression was performed to determine the association between RRT and mortality.
Results: We analyzed 221 patients; the mean age was 49.8 years, and 55.2% were men. Mortality was 36.7%. IHD was used in 73.8% and CRRT in 26.2% of cases. In the group treated with CRRT, the severity of disease was higher, the recovery of renal function less frequent, the need for long-term RRT less frequent, and mortality higher, compared with those treated with IHD. CRRTs had an odds ratio (OR) of 8.64 for mortality (p = 0.063).
Conclusions: IHD is the RRT most frequently used. Mortality is higher in patients treated with CRRT. CRRTs are not an independent risk factor for death.


REFERENCES

  1. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P and and the ADQI workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. Crit Care. 2004;8(4):R204-R212.

  2. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.

  3. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;25;380(9843):756-66.

  4. Nisula S, Kaukonen KM, Vaara ST, Korhonen AM, Poukkanen M, Karlsson S, et al.; FINNAKI Study Group. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intensive Care Med. 2013;39(3):420-8. doi: 10.1007/s00134-012-2796-5.

  5. Wijewickrama ES, Ratnayake GM, Wikramaratne C, Sheriff R, Rajapakse S. Incidences and clinical outcomes of acute kidney injury in ICU: a prospective observational study in Sri Lanka. BMC Res Notes. 2014.19;7:305. doi: 10.1186/1756-0500-7-305.

  6. Van Berendoncks AM, Elseviers MM, Lins RL; SHARF Study Group. Outcome of acute kidney injury with different treatment options: long-term followup. Clin J Am Soc Nephrol. 2010;5(10):1755-62. doi: 10.2215/CJN.00770110.

  7. Coca SG, Yusuf B, Shlipak MG. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53(6):961-73.

  8. Ahlström A, Tallgren M, Peltonen S, Räsänen P, Pettilä V. Survival and quality of life of patients requiring acute renal replacement therapy. Intensive Care Med. 2005;31:1222-8.

  9. Kidney Disease Outcomes Quality Initiative. KDIGO clinical practice guidelines for acute kidney injury. Kidney Int Suppl. 2012;2:1-138.

  10. Palevsky PM. Renal replacement therapy in AKI supplements. Adv Chronic Kidney Dis. 2013;20(1): 76-84.

  11. Kellum JA. Indications, timing, and patient selection. In: Kellum JA, Bellomo R, Ronco C, eds. Continuous Renal Replacement Therapy. 1st ed. New York, NY: Oxford University Press; 2015. pp. 39-46.

  12. Koyner JL, Garg AX, Thiessen-Philbrook H, Coca SG, Cantley LG, Peixoto A, et al. Adjudication of etiology of acute kidney injury: experience from the TRIBE-AKI multi-center study. BMC Nephrol. 2014 Jul 4;15:105. doi: 10.1186/1471-2369-15-105.

  13. Marshall MR, Juncos LA. Dialytic management of acute kidney injury and intensive care unit nephrology. In: Johnson RJ, Feehally J, Floege J, eds. Comprehensive Clinical Nephrology. 5th ed. Philadelphia, PA: Elsevier Saunders; 2015. pp. 855-66.

  14. Cerda J, Ronco C. Choosing a renal replacement therapy in acute kidney injury. In: Kellum JA, Bellomo R, Ronco C, eds. Continuous Renal Replacement Therapy. 1st ed. New York, NY: Oxford University Press; 2015. pp. 79-92.

  15. Uppalapati A, Kellum JA. The critically ill patient with acute kindney injury. In: Kellum JA, Bellomo R, Ronco C, eds. Continuous Renal Replacement Therapy. 1st ed. New York, NY: Oxford University Press; 2015. pp. 3-9.

  16. Uehlinger DE, Jakob SM, Ferrari P. Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant. 2005;20:1630-7.

  17. Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, et al.; Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet. 2006;368(9533):379-85.

  18. Bell M; SWING, Granath F, Schön S, Ekbom A, Martling CR. Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med. 2007;33(5):773-80.

  19. Rabindranath K, Adams J, Macleod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD003773.

  20. Schneider AG, Bellomo R, Bagshaw SM, Glassford NJ, Lo S, Jun M, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and metaanalysis. Intensive Care Med. 2013;39:987-97.

  21. Knaus WA, Draper EA, Wagner DP, Zimmermann JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-29.

  22. Wald R, Shariff SZ, Adh kari NK, Bagshaw SM, Burns KE, Friedrich JO, et al. The association between renal replacement therapy modality and longterm outcomes among critically ill adults with acute kidney injury: a retrospective cohort study. Crit Care Med. 2014;42:868-77.

  23. Ronco C, Ricci Z, De Backer D, Kellum JA, Taccone FS, Joannidis M, et al. Renal replacement therapy in acute kidney injury: controversy and consensus. Crit Care. 2015;19:146.

  24. Choi HM, Kim SC, Kim MG, Jo SK, Cho WY, Kim HK. Etiology and outcomes of anuria in acute kidney injury: a single center study. Kidney Res Clin Pract. 2015;34:13-9.

  25. Ethgen O, Schneider AG, Bagshaw SM, Bellomo R, Kellum JA. Economics of dialysis dependence following renal replacement therapy for critically ill acute kidney injury patients. Nephrol Dial Transplant. 2015 Jan;30(1):54-61. doi: 10.1093/ndt/gfu314.

  26. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012 Mar;81(5):442-8. doi: 10.1038/ki.2011.379.




2020     |     www.medigraphic.com